Home
Categories
EXPLORE
Music
Society & Culture
True Crime
Comedy
News
Religion & Spirituality
Business
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/68/90/80/6890802c-9bae-5f89-7110-aa862890d62e/mza_18256788403456875418.jpg/600x600bb.jpg
Is That a Thing?
Dr Anthony Hackett
19 episodes
5 months ago
Dive deep into the history of medicine to explore the origins of penicillin and the development of cephalosporins. From the dank corners of Alexander Fleming's lab to the sewers of Sardinia we explore the history and controversy behind some of the most common antibiotics. We will also discuss whether or not penicillin allergy is real and if you can give a penicillin allergic patient a cephalosporin and still keep your license to practice medicine.
Show more...
Medicine
Health & Fitness
RSS
All content for Is That a Thing? is the property of Dr Anthony Hackett and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Dive deep into the history of medicine to explore the origins of penicillin and the development of cephalosporins. From the dank corners of Alexander Fleming's lab to the sewers of Sardinia we explore the history and controversy behind some of the most common antibiotics. We will also discuss whether or not penicillin allergy is real and if you can give a penicillin allergic patient a cephalosporin and still keep your license to practice medicine.
Show more...
Medicine
Health & Fitness
https://storage.buzzsprout.com/tvzhay8kwg6mo56ev63gtksan8z8?.jpg
Intermediate risk pulmonary embolism treatment
Is That a Thing?
33 minutes
4 years ago
Intermediate risk pulmonary embolism treatment
This episode focuses on treatment options for intermediate-risk pulmonary emboli (PE). We define the intermediate-risk (or submassive )PE and controversies surrounding its detection including imaging and laboratory evaluation. Evidence suggests that it is not only the PE that makes it intermediate risk but also the kind of patient that we find the PE in. Most of our time in the episode we discuss therapies, specifically thrombolytics, and the evidence and controversy behind ...
Is That a Thing?
Dive deep into the history of medicine to explore the origins of penicillin and the development of cephalosporins. From the dank corners of Alexander Fleming's lab to the sewers of Sardinia we explore the history and controversy behind some of the most common antibiotics. We will also discuss whether or not penicillin allergy is real and if you can give a penicillin allergic patient a cephalosporin and still keep your license to practice medicine.